MYCN has also been shown to transcriptionally up-regulate p53 in neuroblastoma, which in turn increases the levels of mouse double minute 2 (MDM2) and p53 up-regulated modulator of apoptosis.118. This evidence concerns the gene TP53 and neuroblastoma.